System Changes
for Better Health

Date & time
4-5 November 2026
Location
KBR – Royal Library of Belgium
Boulevard de l’Empereur 2
1000 Brussels, Belgium
About the event
PharmaSupply, GIRP’s flagship conference on the pharmaceutical supply chain, will bring together EU regulators, policymakers, industry leaders, and healthcare stakeholders at its 2026 edition to address the regulatory, operational, and technological changes reshaping Europe’s medicines supply chain.
PharmaSupply 2026 will provide a platform to understand, anticipate, and respond to the regulatory developments, structural challenges, and innovation opportunities facing the pharmaceutical supply chain in Europe.
Key topics
Exploring tomorrow’s health systems
The conference will focus on:
- Examining the implementation of the General Pharmaceutical Legislation and what it means in practice for distributors, manufacturers, and regulators across the supply chain.
- Discussing the revision of GDP guidelines and the evolving landscape of pharmaceutical inspections.
- Addressing medicines shortages and the role of systemic wholesalers in ensuring resilience and equitable access.
- Exploring the role of data, digital transformation, and supply chain innovation in building a more sustainable and transparent distribution system.
Confirmed speakers
- Rui Santos Ivo, Chairman of the Board, EMA
- Hugues Malone, CEO, Federal Agency for Medicines and Healthcare Products, Belgium
- Elizabeth Theophille, Chief Digital Transformation Officer, Sandoz
- Katarina Gabrielson, CEO, Oriola
- Emil Schwan, Scientific Specialist, EMA
- Manuel Ibarra Lorente, Head of Department, Pharmaceutical Inspection and Enforcement Department, AEMPS
- Koen Straetmans, CEO, Febelco
- Ilaria Passarani, Secretary General, PGEU
Further speakers to be announced
A flagship European health event
Hosted by GIRP, the voice of systemic pharmaceutical wholesalers in Europe, PharmaSupply 2026 will serve as a platform for high-level dialogue between regulators, policymakers, wholesalers, manufacturers, and healthcare stakeholders on the key challenges and opportunities shaping the future of pharmaceutical distribution in Europe.
Join us and contribute to the discussions shaping the future of Europe’s medicines supply chain!







